How much is Gemstone Biotherapeutics worth in 2026?

Gemstone Biotherapeutics has a current valuation of N/A based on their Accelerator/Incubator round and secondary market data.

How much funding has Gemstone Biotherapeutics raised?

Gemstone Biotherapeutics has raised N/A in total funding across 1 funding rounds.

Gemstone Biotherapeutics

Biotechnology

Gemstone Biotherapeutics valuation and funding history | Last updated: January 1, 2019 | 1 funding rounds

Current Valuation

N/A

As of January 1, 2019

Total Funding Raised

N/A

Across 1 round

Last Round

Accelerator/Incubator

Amount undisclosed

Last Funding

Jan 2019

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 1, 2019	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Gemstone Biotherapeutics is currently valued at N/A as of January 1, 2019.

Track Gemstone Biotherapeutics Valuation Updates

Get notified when Gemstone Biotherapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Gemstone Biotherapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Gemstone Biotherapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Gemstone Biotherapeutics Worth in 2026?

Gemstone Biotherapeutics is a leading private company in the Biotechnology sector. Track Gemstone Biotherapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Gemstone Biotherapeutics Valuation is Determined

Private company valuations like Gemstone Biotherapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.